Limited data underlines a variable metastatic potential that allows this carcinoma to involve any organ by affecting certain genes and proteins, including p53, E-cadherin, Bcl-2, and insulin-like growth factor binding protein 2 gene [2]. The gene discussed is TP53; the disease is carcinoma.